CCM OPEN HF Registry
Purpose
The registry has been designed to evaluate the long-term safety and efficacy of CCM therapy in a real-world setting.
Condition
- Heart Failure
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Patients who have /will be implanted with Impulse Dynamics CCM technologies (e.g. CCM or CCM-D when available) as determined by investigators - Willing and able to provide informed consent, including for use of data for research purposes (e.g. publication, sub-studies/sub-analyses)
Exclusion Criteria
- Noncompliant patients (e.g. for follow-up visits, medication, etc.) as determined by investigators. - Subjects with a mechanical tricuspid valve
Study Design
- Phase
- Study Type
- Observational [Patient Registry]
- Observational Model
- Cohort
- Time Perspective
- Cross-Sectional
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| Retrospective Cohort | Prospective Cohort | |
| Hybrid (Retrospective-Prospective) Cohort | Patients who will receive/ have received CCM therapy with an Impulse Dynamics devices | |
| Prospective Cohort | Patients who will receive CCM therapy with an Impulse Dynamics devices |
Recruiting Locations
Cardiovascular Associates of Mesa
Mesa, Arizona 85206
Mesa, Arizona 85206
Peak Heart and Vascular
Surprise, Arizona 85378
Surprise, Arizona 85378
Massachusetts General Hospital
Boston, Massachusetts 02144
Boston, Massachusetts 02144
The Stern Cardiovascular Foundation, Inc
Germantown, Tennessee 38138
Germantown, Tennessee 38138
David Turbay, MD
El Paso, Texas 79905
El Paso, Texas 79905
Centra Health, Inc. dba Stroobants Cardiovascular Center
Lynchburg, Virginia 24501
Lynchburg, Virginia 24501
More Details
- Status
- Recruiting
- Sponsor
- Impulse Dynamics
Detailed Description
This is a global, prospective and retrospective, multicenter, single-arm, observational study intended to include patients who will receive/have received CCM therapy with an Impulse Dynamics system, including future CCM technologies (e.g. CCM-D), for a follow-up period of at least 5 years.